Cancer Gene Therapy
New cancer gene therapy research reported from Zhejiang University, Institute of Immunology
Published in Gene Therapy Weekly, June 4th, 2009
Current study results from the report, 'EBAG9 inducing hyporesponsiveness of T cells promotes tumor growth and metastasis in 4T1 murine mammary carcinoma,' have been published. According to a study from Hangzhou, People's Republic of China, "The estrogen receptor-binding fragment-associated gene 9 (EBAG9) has been identified as an estrogen-responsive gene and was recently identified as a tumor-promoting and prognostic factor for renal cell carcinoma. We investigated whether EBAG9 expression was correlated with primary tumor growth and distant tumor metastasis in a murine breast carcinoma model."
"Knockdown expression of EBAG9 by small interfering RNA significantly...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
Source: Gene Therapy Weekly (2009-06-04)
More Articles from Gene Therapy Weekly
- Autoimmune Disease
Researchers from University of Rochester report recent findings in autoimmune disease - Autoimmune Lymphoproliferative Syndrome
Investigators at National Institutes of Health have published new data on autoimmune lymphoproliferative syndrome - Bioengineering
Investigators at University of Maryland have published new data on bioengineering - Cancer Gene Therapy
New cancer gene therapy findings from University of Saskatchewan described - Cancer Gene Therapy
Research from Central South University has provided new information about cancer gene therapy - Cervical Cancer
Research on cervical cancer published by H. Chen et al - More from this issue of Gene Therapy Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
